Clinical Trial

Trial Protocol ID USOR 22067_PRO1184-001

Trial Description

Phase 1/2 Study of PRO1184 in Patients with Locally Advanced and/or Metastatic Solid Tumors 

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • John Wallmark, MD

Disease Types

Sponsors

  • Precision for Medicine
  • ProfoundBio US Co.

ClinicalTrials.gov NCT ID

  • NCT05579366